InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+17.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Stokes Frank, Chief Financial Officer. Insider active across 1 company, notably Castle Biosciences INC. In total, 15 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €486k. History available since 15 June 2021. The latest transaction was disclosed on 20 February 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
12,186 sharesCommon StockSEC:0001447362-25-000034:0
8,046 shares@ US$26.7037.0% of flowCommon StockSEC:0001447362-25-000019:0
14,617 sharesCommon StockSEC:0001447362-24-000196:0
6,123 shares@ US$29.8731.2% of flowCommon StockSEC:0001447362-24-000187:0
9,745 shares0Common StockSEC:0001447362-24-000130:0
4,600 shares@ US$25.19719.0% of flowCommon StockSEC:0001447362-24-000129:0
14,617 sharesCommon StockSEC:0001447362-23-000177:0
4,000 shares@ US$3.382.2% of flowCommon StockSEC:0001447362-23-000056:0
2,000 sharesCommon StockSEC:0001447362-22-000196:0
4,000 shares@ US$3.380.0011% mcap22.2% of flowCommon StockSEC:0001447362-22-000089:0
1,114 sharesCommon StockSEC:0001447362-22-000072:0
2,000 sharesCommon StockSEC:0001447362-21-000272:0
2,000 sharesCommon StockSEC:0001447362-21-000272
11,600 shares@ US$2.394.1% of flowCommon StockSEC:0001447362-21-000148
11,600 shares@ US$2.390.0020% mcap38.9% of flowCommon StockSEC:0001447362-21-000148:0
15 of 15 declarations
About Stokes Frank
Frank Stokes is the Chief Financial Officer of Castle Biosciences Inc. As CFO, he oversees the company's financial operations, including financial planning, risk management, and financial reporting. Frank plays a crucial role in developing financial strategies that support the company's mission. His experience in finance and investment management is a significant asset for Castle Biosciences.
